Icon

XTORO (nda206307)- (0.3%)

FINAFLOXACIN FONSECA BIOSCIENCES
0.3%
No No
2033-Nov-21 2019-Dec-17
None None
None No
XTORO is a quinolone antimicrobial indicated for the treatment of acute otitis externa (AOE) caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus.
0 0 0
Total Other Developers None
Drugs with Suitability No
0.3% ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.